Quantitative EEG Matches MEG in Mapping Juvenile Myoclonic Epilepsy

Scalp EEG recorded from 22 adolescents with juvenile myoclonic epilepsy (JME) has captured occipital abnormalities previously visible mainly with magnetoencephalography, according to a multi-hospital study funded by Kaohsiung Medical University Hospital and Taiwan's National Science and Technology Council. The patient group showed stronger long-range temporal correlations (persistence of a signal's statistical structure over time), higher signal complexity, higher relative delta power, and lower relative alpha power over the occipital region compared with 22 age- and sex-matched controls aged 10 to 18 years.

The study set out with two objectives. First, the authors tested whether advanced quantitative EEG analysis could reach a spatial resolution comparable to that of MEG while keeping the practical advantages of scalp recording. Second, they asked whether the EEG-derived patterns correspond to the clinical hallmark of JME, namely photosensitivity, in which visual stimuli trigger seizures.

How the cohort was defined

All 22 patients received a JME diagnosis based on International League Against Epilepsy criteria: myoclonic seizures plus generalized 3 to 5.5 Hz spike-wave or polyspike-wave discharges on EEG. The researchers excluded patients with age at onset below 8 or above 40 years, or with moderate to severe comorbidities.

Within the patient group, 7 of 22 were classified as EEG-photosensitive, showing a photoparoxysmal response during intermittent photic stimulation; 12 were non-photosensitive, and 3 did not undergo photic stimulation and could not be classified. Mean age did not differ significantly between patients and controls (13.9 ± 2.25 vs. 14.3 ± 2.36 years; p = 0.54).

What did the occipital changes mean?

The spectral results pointed to a redistribution of power rather than a simple increase or decrease in overall activity. Relative power measures each frequency band's proportional contribution to total spectral power, so a rise in one band forces a proportional fall in others even when absolute power stays constant.

In the JME group, occipital relative delta power rose while relative alpha power fell. The authors located these changes in the occipital lobe, the primary visual processing region containing the primary visual cortex and visual association areas. That spatial pattern matches the known pathophysiology of photosensitivity in JME: roughly 40% of all JME patients are photosensitive, and flickering light can induce synchronous activity in occipital neurons that propagates anteriorly through cortico-cortical circuits toward frontal and parietal regions, triggering generalized discharges.

The study also found elevated signal complexity and stronger long-range temporal correlations in the patient group, two measures of how EEG fluctuations organize across time.

Why the MEG comparison matters

The key claim rests on convergence between modalities. The spatial and spectral patterns identified through scalp EEG were consistent with previously reported MEG findings in JME, which the authors read as evidence that advanced EEG can deliver neurophysiological characterization comparable to MEG at far lower cost and with far greater portability.

MEG retains superior spatial localization, and the authors acknowledge that advantage. Their argument is practical rather than absolute: EEG offers millisecond-scale temporal resolution, sufficient spatial information when paired with brain topography, and the accessibility required for routine clinical use and large-scale studies.

What could change in the reading room?

For clinical neurophysiology teams, the findings suggest a pathway toward quantitative occipital biomarkers — relative delta and alpha power, complexity, and temporal correlation measures — extracted from routine scalp EEG already acquired during JME workups, including intermittent photic stimulation protocols. The study is exploratory, with a modest cohort of 22 patients recruited from multiple hospitals, and the investigators frame the biomarkers as candidates rather than validated diagnostic tools.

No FDA-cleared quantitative EEG device for JME characterization emerged from this work; the analysis remains investigational research on human data. The findings lay the groundwork for larger studies testing whether these occipital EEG signatures can stratify photosensitive patients and track them across health-care settings where MEG is unavailable.